- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01167361
Epidemiology Of Respiratory Virus Infections In Children
October 30, 2012 updated by: St. Jude Children's Research Hospital
This study aims to prospectively estimate the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) at St. Jude Children's Research Hospital (SJCRH) using the FilmArrayTM System, a novel highly sensitive and rapid assay for RV detection.
An aliquot from the leftover sample remaining after clinical diagnostic testing will be used for FilmArrayTM analysis.
Patients will be accrued on the study over a one year period.
Study Overview
Status
Completed
Conditions
Detailed Description
The Primary Objective of the study is:
- Prospectively estimate the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) at St. Jude Children's Research Hospital(SJCRH).
The Secondary Objectives of the study are:
- Study the association between RV infections and clinical variables.
- Prospectively estimate the duration of RV infections in symptomatic children at SJCRH.
- Compare the sensitivity and specificity of the current molecular method of analysis of respiratory viruses with the FilmArrayTM method.
Study Type
Observational
Enrollment (Actual)
350
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105
- St . Jude Children's Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with an URTI or LRTI undergoing collection of respiratory secretions at St Jude by nasopharyngeal wash, nasopharyngeal swab, tracheal aspirate or bronchoalveolar lavage as ordered by the treating physician.
Description
Inclusion Criteria:
- Birth to less than or equal to 18 years.
- Patients with an URTI or LRTI undergoing collection of respiratory secretions at SJCRH, by nasopharyngeal wash, nasopharyngeal swab, tracheal aspirate or bronchoalveolar lavage as ordered by the treating physician.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Children with upper or lower respiratory infections
Respiratory Virus infections in children who are symptomatic with either an Upper Respiratory Tract Infections and/or Lower Respiratory Tract Infections is determined by using a novel highly sensitive and rapid assay for RV detection.
An aliquot from the leftover sample remaining after clinical diagnostic testing will be used for FilmArrayTM analysis.
Specimens collected will include nasopharyngeal washes, nasopharyngeal swabs, tracheal aspirates and bronchoalveolar lavage as ordered by the treating physician.
Diagnostic studies on this specimen will be performed as ordered and the results will be available to the treating physicians after reporting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
This study measures the incidence of Respiratory virus (RV) infections in children with symptoms of an upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) using the FilmArray System
Time Frame: 1 year
|
This study uses FilmArrayTM System, a novel highly sensitive and rapid assay for respiratory virus infection.
An aliquot from the leftover sample remaining after clinical diagnostic testing will be used for FilmArrayTM analysis
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time of first detection of the virus as related to day of transplant, Time of first detection of the virus as related to day of chemotherapy and duration of viral shedding from the time of first detection will all be measured.
Time Frame: 1 year
|
Different variables will be collected to find the association between Respiratory virus and clinical variables
|
1 year
|
|
This study prospectively estimates and measures the duration of Respiratory Virus infections in symptomatic children by studying the epidemiology and natural history of infections with these viruses .
Time Frame: 1 year
|
These viruses have been known to cause interstitial lung disease, will help clarify the etiology of "idiopathic pneumonia" post chemotherapy .
|
1 year
|
|
This study analyses respiratory viruses using Filmarray TM method
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
July 20, 2010
First Submitted That Met QC Criteria
July 21, 2010
First Posted (Estimate)
July 22, 2010
Study Record Updates
Last Update Posted (Estimate)
October 31, 2012
Last Update Submitted That Met QC Criteria
October 30, 2012
Last Verified
July 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XPD10-082 RESVPI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Virus Infection
-
Sanofi Pasteur, a Sanofi CompanyCompletedRespiratory Syncytial Virus Infection | Metapneumovirus Infection | Parainfluenzae Virus InfectionAustralia
-
Menzies School of Health ResearchUniversity of Sydney; Murdoch Childrens Research InstituteNot yet recruitingRespiratory Syncytial Virus (RSV) | Respiratory Infection VirusAustralia
-
Kenneth RockwoodNova Scotia Health Authority; Research Nova Scotia; Department of Health, Nova...CompletedCOVID-19 Respiratory Infection | Influenza -Like Illness | Respiratory Virus InfectionCanada
-
PfizerTerminatedRespiratory Syncytial Virus InfectionUnited States, India, China, Japan
-
Nicola IrwinThe University of New South Wales; Kirby InstituteCompletedRespiratory Syncytial Virus Hospitalizations | Respiratory Syncytial Virus (RSV) Infection | Respiratory Syncytial Virus ImmunizationAustralia
-
Jiangsu Simcere Pharmaceutical Co., Ltd.CompletedEfficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaInfluenza A Virus Infection | Influenza B Virus InfectionChina
-
Marshfield Clinic Research FoundationUniversity of Wisconsin, Madison; Centers for Disease Control and PreventionCompletedInfluenza A Virus Infection | Influenza B Virus Infection | Immune Response to Influenza VaccineUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers | Respiratory Syncytial Virus Infection | Metapneumovirus InfectionAustralia, United States
-
Shenzhen Shenxin Biotechnology Co., LtdActive, not recruitingRespiratory Syncytial Virus (RSV) InfectionChina
-
University of ManitobaHoffmann-La RocheWithdrawnInfluenza A Virus Infection | Influenza B Virus InfectionCanada